These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 8006495)
1. Noninvasive carcinoma of the breast: the rationale for various treatment options. Kuske RR J La State Med Soc; 1994 Apr; 146(4):128-32. PubMed ID: 8006495 [TBL] [Abstract][Full Text] [Related]
2. Current management of noninvasive (in situ) breast cancer. Silverstein MJ Adv Surg; 2000; 34():17-41. PubMed ID: 10997214 [No Abstract] [Full Text] [Related]
3. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. Fisher B; Costantino J; Redmond C; Fisher E; Margolese R; Dimitrov N; Wolmark N; Wickerham DL; Deutsch M; Ore L N Engl J Med; 1993 Jun; 328(22):1581-6. PubMed ID: 8292119 [TBL] [Abstract][Full Text] [Related]
4. The problem of ductal carcinoma in situ of the breast. Fentiman IS Ann Chir Gynaecol; 1992; 81(4):334-6. PubMed ID: 1336650 [TBL] [Abstract][Full Text] [Related]
5. The diagnosis and treatment of breast cancer. Matory YL Curr Opin Gen Surg; 1994; ():217-23. PubMed ID: 7583973 [TBL] [Abstract][Full Text] [Related]
6. Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome. Bradley SJ; Weaver DW; Bouwman DL Am Surg; 1990 Jul; 56(7):428-32. PubMed ID: 2164336 [TBL] [Abstract][Full Text] [Related]
7. Treatment of intraductal breast cancer--noncomedo type. Griffin A; Frazee RC Am Surg; 1993 Feb; 59(2):106-9. PubMed ID: 8386487 [TBL] [Abstract][Full Text] [Related]
8. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis. Ben-David MA; Kleer CG; Paramagul C; Griffith KA; Pierce LJ Cancer; 2006 Jan; 106(1):28-34. PubMed ID: 16329136 [TBL] [Abstract][Full Text] [Related]
9. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience. Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940 [TBL] [Abstract][Full Text] [Related]
10. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment. Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402 [TBL] [Abstract][Full Text] [Related]
11. [Unresolved questions in the indications for the conservative treatment of invasive cancer of the breast]. Zinzindohoué C; Bobin JY Bull Cancer; 1998 Sep; 85(9):763-72. PubMed ID: 9817060 [TBL] [Abstract][Full Text] [Related]
12. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864 [TBL] [Abstract][Full Text] [Related]
13. [Controversies in breast conservation treatment for breast cancer]. Motomura K; Egawa C; Komoike Y; Inaji H; Koyama H Gan To Kagaku Ryoho; 2004 Feb; 31(2):168-75. PubMed ID: 14997746 [TBL] [Abstract][Full Text] [Related]
14. Therapy of in situ cancer. Recht A; Connolly JL; Schnitt SJ; Harris JR Hematol Oncol Clin North Am; 1989 Dec; 3(4):691-708. PubMed ID: 2558105 [TBL] [Abstract][Full Text] [Related]
15. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843 [TBL] [Abstract][Full Text] [Related]
16. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516 [TBL] [Abstract][Full Text] [Related]
17. [Lobular carcinoma in situ as a component of breast cancer points to no contraindication for breast-conserving therapy]. Sautter-Bihl ML Strahlenther Onkol; 2001 Jan; 177(1):51-2. PubMed ID: 11200114 [No Abstract] [Full Text] [Related]
18. [Conservative treatment of sub-clinical noninfiltrating cancers of the breast (102 EOA in situ, TONO)]. Brandone H; Ayme Y; Hans D; Dubau A; Brandone JM; Robert F; Pollet JF; Amalric F; Bressac C; Jacquemier J Ann Chir; 1995; 49(1):56-61. PubMed ID: 7741470 [TBL] [Abstract][Full Text] [Related]
19. [Conservative surgery for ductal carcinoma in situ of the breast]. Tersigni R; Mencacci R; Alessandroni L; Baiano G; Mardarella C; Parisi A Minerva Chir; 2003 Aug; 58(4):563-9. PubMed ID: 14603170 [TBL] [Abstract][Full Text] [Related]
20. Selection criteria for breast conservation in breast cancer. Sakorafas GH; Tsiotou AG Eur J Surg; 2000 Nov; 166(11):835-46. PubMed ID: 11097148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]